ZERO is committed to bridging the gap between racial and health disparities in prostate cancer among Black men. In order to achieve our mission to end prostate cancer, we must also zero out racial disparities in prostate cancer. Here are the troubling facts on how this disease impacts Black men, according to the American Cancer Society:
- African American men are 1.7 times more likely to be diagnosed with prostate cancer than white men.
- African American men are 2.1 times more likely to die from prostate cancer than white men.
- African American men are more likely than white men to be diagnosed with advanced disease.
- Only 33% of African American men over 50 years old have received a PSA test.
These statistics are a result of factors happening within the U.S. healthcare system including access to care issues, racial bias, and distrust in the medical system. ZERO’s Prostate Cancer Health Equity Task Force will help ZERO strengthen existing initiatives, identify new ways, and design solutions to further address these issues in a consistent and impactful manner. Below are the current members of our Task Force:
SVP, Chief Talent and Diversity Officer
Bettina Drake, Ph.D.
Professor of Surgery
Washington University School of Medicine
St. Louis, Missouri
Stanley Frencher, Jr., M.D., MPH
Director, Surgical Outcomes and Quality
MLK Outpatient Center
Los Angeles, CA
Brian A. Jones
Pennsylvania Cancer Coalition Men’s Health Co-Chair;
Board of Directors for the Pennsylvania Prostate Cancer Coalition;
Stacy Loeb, M.D.
Professor, Department of Urology at NYU Grossman School of Medicine;
Professor, Department of Population Health at NYU Grossman School of Medicine;
Urologist, New York University Langone Medical Center & The Manhattan Veterans Affairs Hospital
New York, New York
BlueChild Entertainment, LLC
Aliso Viejo, CA
Kelvin Moses, M.D., Ph.D.
Associate Professor, Department of Urology;
Fellowship Director, Urologic Oncology Fellowship, Division of Urologic Oncology,
Vanderbilt University Medical Center
Joseph Osborne, M.D., Ph.D.
Chief of Molecular Imaging and Therapeutics
Weill Cornell School of Medicine
New York, New York
Visionary Director/General Manager
LaMonica Stewart, Ph.D.
Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology
Meharry Medical College
Sherrie Wallington, Ph.D.
Assistant Professor, Health Disparities & Oncology
Milken Institute School of Public Health; GW Scool of Nursing
Read blog posts from our Task Force Co-Chairs on the stark contrasts between white and Black men in prostate cancer, and learn about how prostate cancer and COVID-19 similarly affect the Black community.